Abstract:Background: Several types of microRNAs (miRNAs) have recently been defined as important regulators in adipocyte differentiation, the role of other miRNAs in the processes and the mechanisms involved remain to be explored. Methods: miR-20a expression was quantified in primary cultured marrow stromal cells and adipogenic cell lines after adipogenic treatment. Effects of miR-20a on adipocyte differentiation were studied following supplementing or depleting miR-20a in murine 3T3-L1 preadipocytes, ST2 stromal cells and C3H10T1/2 mesenchymal cells. Bioinformatics prediction of miRNA targets was performed, and potential targets of miR-20a were verified by using dual luciferase activity assays. Gain-of-function and loss-of-function studies were performed to examine the effects of the target genes on adipocyte differentiation. Results: miR-20a was induced in primary cultured marrow stromal cells and established adipogenic lines after adipogenic treatment. Supplementing miR-20a activity suppressed the growth of 3T3-L1 preadipocytes and induced 3T3-L1, ST2 and C3H10T1/2 cells to differentiate into mature adipocytes, along with the induction of adipocyte-specific transcription factors peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer binding protein-α (C/EBPα), C/EBPβ and the marker gene adipocyte protein 2 (aP2). Conversely, inhibition of the endogenous miR-20a repressed 3T3-L1, ST2 and C3H10T1/2 cells to fully differentiate. Transforming growth factor-β receptor II (Tgfbr2) and lysine-specific demethylase 6b (Kdm6b) were shown to be direct targets of miR-20a. Supplementing miR-20a activity in ST2 reduced levels of KDM6B and TGFBR2 proteins, while suppression of endogenous miR-20a increased KDM6B and TGFBR2. While TGF-β signaling is a well-documented inhibitor of adipogenesis, the effects of Kdm6b on adipocyte formation need to be clarified. We demonstrated that overexpression of Kdm6b inhibited, while knockdown of Kdm6b promoted the differentiation of the ST2 cells into mature adipocytes. Conclusion: The present work provides evidence that mouse miR-20a promotes adipocyte progenitor cells to differentiate and this function may depend upon its inhibitory effects on Kdm6b and TGF-β signaling.

MiR-503 Inhibits Adipogenesis by Targeting Bone Morphogenetic Protein Receptor 1A.

MiR-196b-3p and Mir-450B-3p Are Key Regulators of Adipogenesis in Porcine Intramuscular and Subcutaneous Adipocytes.

Mir-133A Regulates Adipocyte Browning in Vivo.

Mir-10B-5p Regulates 3T3-L1 Cells Differentiation by Targeting Apol6.

miR-370-3p Regulates Adipogenesis through Targeting Mknk1

miR-196b-5p controls adipocyte differentiation and lipogenesis through regulating mTORC1 and TGF- signaling

Mir-140-5p Regulates Adipocyte Differentiation by Targeting Transforming Growth Factor-Β Signaling

Mir-144-3p Promotes Adipogenesis Through Releasing C/EBPα from Klf3 and CtBP2

MicroRNA-143a-3p Modulates Preadipocyte Proliferation and Differentiation by Targeting MAPK7

Insulin receptor substrate-1 inhibits high-fat diet-induced obesity by browning of white adipose tissue through miR-503

Bta-miR-484 Targets SFRP1 and Affects Preadipocytes Proliferation, Differentiation, and Apoptosis.

MicroRNA-204-5p Regulates 3T3-L1 Preadipocyte Proliferation, Apoptosis and Differentiation

Mir-152 Regulates 3T3-L1 Preadipocyte Proliferation and Differentiation

miR-20a regulates adipocyte differentiation by targeting lysine-specific demethylase 6b and transforming growth factor-β signaling

MiR-144-3p Targets FoxO1 to Reduce Its Regulation of Adiponectin and Promote Adipogenesis

miR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2

The role of miR-301b in the regulation of adipocyte differentiation

MiR-145 Reduces the Activity of PI3K/Akt and MAPK Signaling Pathways and Inhibits Adipogenesis in Bovine Preadipocytes.

MiR‐25 Suppresses 3T3‐L1 Adipogenesis by Directly Targeting KLF4 and C/EBPα

Mir-199A-3p Regulates Brown Adipocyte Differentiation Through Mtor Signaling Pathway

MiR-378a-3p Enhances Adipogenesis by Targeting Mitogen-Activated Protein Kinase 1.